EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

High SPINK1 Immunostaining in Colorectal Carcinoma is Associated with Poor Outcomes

Ola Nasser iD, Wafaey Gomaa iD, Wafaa Aref, Rabab Moussa iD

Sultan Qaboos University Medical Journal · 21.07.2025 · 25 (1) · 681-688

DOI: 10.18295/2075-0528.2889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sultan Qaboos University Medical Journal, online erschienen am 21.07.2025. Verfasst von Ola Nasser und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Minia University, Al-Minia, Egypt. Hauptthemen laut MEDLINE: Trypsin Inhibitor, Kazal Pancreatic, Colorectal Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Colorectal cancer (CRC) is the third most common cancer worldwide and is the second leading cause of cancer-related deaths. Serine protease inhibitor Kazal-type 1 (SPINK1) is found to be related to poor prognostic criteria and shortened overall survival of some malignancies such as liver, breast, lung, pancreatic and renal cancers. SPINK1 can be a potential biomarker for early detection and prediction of immune checkpoint blockade treatment response. Therefore, this study aimed to examine the possible role of SPINK1 in colorectal carcinogenesis and its prognostic ability.

Methods

This study used paraffin blocks of patients diagnosed with colorectal adenoma, primary CRC and available positive lymph node metastases. Specimens were obtained between April 2018 and June 2022 at the Department of Pathology, Faculty of Medicine, Minia University, Egypt. Immunohistochemistry was done for SPINK1 antibody and appropriate statistical analysis of results was performed.

Results

A total of 70 archival samples of CRC, 18 of colorectal adenoma and 20 of metastatic lymph nodes were used in this study. In a normal colon, there was a negative to weak SPINK1 immunostaining. High cytoplasmic immunostaining was seen in 57.1% of patients while low immunostaining in 42.9% of CRC. SPINK1 immunostaining was statistically associated with tumour grade (P = 0.024), stage (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypsin Inhibitor, Kazal PancreaticColorectal NeoplasmsHumansMaleFemaleMiddle AgedPrognosisAgedImmunohistochemistryBiomarkers, TumorAdultEgyptLymphatic Metastasis

Stichwörter der Autor:innen

Colorectal CancerEgyptImmunohistochemistryPrognosisSPINK1

Substanzen

Trypsin Inhibitor, Kazal PancreaticSPINK1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine, Minia University, Al-Minia, Egypt.

ORCID-Profile: Ola Nasser, Wafaey Gomaa, Rabab Moussa

Zitieren

APA

Nasser, O., Gomaa, W., Aref, W., & Moussa, R. (2025). High SPINK1 Immunostaining in Colorectal Carcinoma is Associated with Poor Outcomes. Sultan Qaboos University Medical Journal, 25(1), 681-688. https://doi.org/10.18295/2075-0528.2889

Vancouver

Nasser O, Gomaa W, Aref W, Moussa R. High SPINK1 Immunostaining in Colorectal Carcinoma is Associated with Poor Outcomes. Sultan Qaboos University Medical Journal. 2025;25(1):681-688. doi:10.18295/2075-0528.2889

BibTeX
@article{Nasser2025,
  author = {Nasser, Ola and Gomaa, Wafaey and Aref, Wafaa and Moussa, Rabab},
  title = {High SPINK1 Immunostaining in Colorectal Carcinoma is Associated with Poor Outcomes},
  journal = {Sultan Qaboos University Medical Journal},
  year = {2025},
  volume = {25},
  number = {1},
  pages = {681--688},
  doi = {10.18295/2075-0528.2889}
}
Kostenlos starten →